Inici › Diabetis tipus 2 › Alabama › Birmingham
Assaigs clínics de Diabetis tipus 2 a Birmingham, AL
16 estudis de Diabetis tipus 2 busquen participants en centres de Birmingham i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
Reclutant
- University of Alabama, Birmingham
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
Reclutant
- University of Alabama, Birmingham
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
ReclutantFase 3
- Cahaba Research, Inc. - Trussville Location, Birmingham
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
ReclutantFase 3
- Birmingham Clinical Research, Birmingham
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
ReclutantFase 3
- AURORA-2 Clinical Site, Birmingham
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
ReclutantFase 2
- Central Research Associates - Flourish - PPDS, Birmingham
- AES - DRS - Synexus Clinical Research US, Inc. - Birmingham, Birmingham
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
ReclutantFase 2
- Flourish Research, Birmingham
Advancing Diabetes Management for People With Physical Disabilities Optimally Through Primary Care-Based Telehealth (ADDOPT)
Reclutant
- UAB Highlands Hospital/Department of Family and Community Medicine, Birmingham
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
ReclutantFase 3
- Research Site, Birmingham
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
ReclutantFase 3
- Univ of Alabama Birmingham, Birmingham
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
ReclutantFase 3
- Research Site, Birmingham
CGM for Management of Type 2 Diabetes in Pregnancy
Reclutant
- University of Alabama at Birmingham, Birmingham
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
ReclutantFase 2
- Central Research Associates, LLC dba Flourish Research, Birmingham
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
ReclutantEstudi observacional
- University of Alabama at Birmingham, Birmingham
FELLAShip to Better Health
Reclutant
- The Worship Center Cristian Church, Birmingham
A Low-Carb Approach to Treat Type 2 Diabetes in Pediatric Patients
Reclutant
- University of Alabama at Birmingham/ Children's of Alabama, Birmingham
Assaigs de Diabetis tipus 2 en altres ciutats
- San Antonio, TX37 estudis
- Houston, TX31 estudis
- Orlando, FL24 estudis
- Boston, MA20 estudis
- Miami, FL19 estudis
- Chicago, IL19 estudis
- Dallas, TX19 estudis
- Columbus, OH18 estudis
- Las Vegas, NV18 estudis
- Atlanta, GA17 estudis
- San Diego, CA17 estudis
- Los Angeles, CA16 estudis
Altres estudis a Birmingham
- Càncer (tots els tipus)30 estudis
- Càncer de mama24 estudis
- Obesitat23 estudis
- Càncer d'ovari23 estudis
- Càncer de pulmó de cèl·lules no petites22 estudis
- Leucèmia mieloide aguda21 estudis
- Mieloma múltiple18 estudis
- EPOC17 estudis
- Malaltia cardiovascular17 estudis
- Sobrepès16 estudis
- Càncer d'endometri16 estudis
- Fibrosi quística16 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.